MY106271A - Cyclosporin ophthalmic compositions. - Google Patents

Cyclosporin ophthalmic compositions.

Info

Publication number
MY106271A
MY106271A MYPI89001487A MYPI19891487A MY106271A MY 106271 A MY106271 A MY 106271A MY PI89001487 A MYPI89001487 A MY PI89001487A MY PI19891487 A MYPI19891487 A MY PI19891487A MY 106271 A MY106271 A MY 106271A
Authority
MY
Malaysia
Prior art keywords
ophthalmic compositions
compositions
cyclosporin
tissues
eye
Prior art date
Application number
MYPI89001487A
Inventor
Ronald Edward Peeples Dr
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY106271A publication Critical patent/MY106271A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NOVEL OPHTHALMIC COMPOSITIONS COMPRISING A CYCLOSPORIN, E.G. CICLOSPORIN, AS ACTIVE INGREDIENT, AND A VEGETABLE OIL, PREFERABLY COR OIL, AND A PETROLEUM JELLY, PREFERABLY WHITE PETROLATUM, AS CARRIER. THE COMPOSITIONS ARE USEFUL FOR TOPICAL OPHTHALMIC APPLICATION IN THE TREATMENT OF DISEASES OR CONDITIONS AFFECTING THE EYE, IN PARTICULAR INTERIOR STRUCTURES OR TISSUES OF THE EYE, AS WELL AS OF SURROUNDING OR ASSOCIATED ORGANS OR TISSUES.
MYPI89001487A 1988-10-26 1989-10-26 Cyclosporin ophthalmic compositions. MY106271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
MY106271A true MY106271A (en) 1995-04-29

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001487A MY106271A (en) 1988-10-26 1989-10-26 Cyclosporin ophthalmic compositions.

Country Status (24)

Country Link
JP (1) JPH02164830A (en)
KR (1) KR900005973A (en)
AU (1) AU626928B2 (en)
BE (1) BE1003578A4 (en)
CA (1) CA2001502A1 (en)
CH (1) CH679210A5 (en)
DE (1) DE3935517A1 (en)
DK (1) DK531289A (en)
ES (1) ES2020032A6 (en)
FI (1) FI895064A0 (en)
FR (1) FR2638089A1 (en)
GB (1) GB2224205B (en)
GR (1) GR1000611B (en)
HU (1) HU203046B (en)
IL (1) IL92120A (en)
IT (1) IT1237824B (en)
LU (1) LU87613A1 (en)
MY (1) MY106271A (en)
NL (1) NL8902657A (en)
NO (1) NO894266L (en)
NZ (1) NZ231131A (en)
PT (1) PT92120B (en)
SE (1) SE8903583L (en)
ZA (1) ZA898140B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (en) * 1990-12-17 1995-03-10 Moving Magnet Tech ROTARY SINGLE - PHASE ELECTROMAGNETIC ACTUATOR.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ES2098739T3 (en) * 1992-05-13 1997-05-01 Sandoz Ltd OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN.
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
RU2158601C2 (en) 1994-11-03 2000-11-10 Новартис Аг Novel medicinal forms of cyclosporine for oral administration having simple formulation and bioavailability, and method of preparation thereof
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE29824679U1 (en) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmaceutical compositions
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
ES2402321T3 (en) * 2007-11-05 2013-04-30 Bausch & Lomb Incorporated Water immiscible materials as vehicles for drug supply
WO2010141648A2 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
IL92120A0 (en) 1990-07-12
CH679210A5 (en) 1992-01-15
AU4371589A (en) 1990-05-03
GB2224205A (en) 1990-05-02
NZ231131A (en) 1992-06-25
DK531289D0 (en) 1989-10-25
KR900005973A (en) 1990-05-07
NO894266L (en) 1990-04-27
FI895064A0 (en) 1989-10-25
CA2001502A1 (en) 1990-04-26
NL8902657A (en) 1990-05-16
HU895444D0 (en) 1990-01-28
IL92120A (en) 1994-02-27
BE1003578A4 (en) 1992-04-28
IT1237824B (en) 1993-06-18
GB8924040D0 (en) 1989-12-13
DE3935517A1 (en) 1990-05-03
PT92120A (en) 1990-04-30
NO894266D0 (en) 1989-10-26
GR1000611B (en) 1992-08-31
HUT52394A (en) 1990-07-28
SE8903583D0 (en) 1989-10-26
DK531289A (en) 1990-04-27
GR890100690A (en) 1990-11-29
JPH02164830A (en) 1990-06-25
IT8948485A0 (en) 1989-10-26
AU626928B2 (en) 1992-08-13
GB2224205B (en) 1992-04-15
FR2638089A1 (en) 1990-04-27
PT92120B (en) 1995-06-30
SE8903583L (en) 1990-04-27
HU203046B (en) 1991-05-28
ES2020032A6 (en) 1991-07-16
LU87613A1 (en) 1991-05-07
ZA898140B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
MY106271A (en) Cyclosporin ophthalmic compositions.
MX9702349A (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma.
AU4686689A (en) Biocidal compositions
CA2201310A1 (en) Antineoplastic cocoa extracts and methods for making and using the same
WO2003051294A3 (en) Mitocidal compositions and methods
IL107207A0 (en) Sustained release pharmaceutical compositions
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
ATE296612T1 (en) ACTIVE INGREDIENTS FOR THE TREATMENT OF SENIL XEROSIS AND PREPARATIONS
CA2172513A1 (en) Aminocyclohexylesters and uses thereof
CA2177683A1 (en) Tissue Moisturizing and Antimicrobial Compositions
ATE151640T1 (en) USE OF PROTEASE INHIBITORS AS ANTIEXUDATIVE, ANTIPHLOGISTIC AND ANTIMICROBIAL AGENTS
GEP20002332B (en) Cefalosporin Derivatives
MX9710252A (en) Use of one or more peptides in a cosmetic composition or for the preparation of a medicament.
CA2190505A1 (en) Use of gel formulations as dressing agents
ATE319458T1 (en) MEDICAL COMPOSITIONS FOR TREATING EYE DISEASES
CA2140361A1 (en) Composition and methods for decreasing muscle breakdown
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
FR2753371B1 (en) USE OF AN EXTRACT FROM THE TERMINALIA CATAPPA PLANT AND DERMATOLOGICAL AND PHARMACEUTICAL COSMETIC COMPOSITIONS COMPRISING SUCH EXTRACT
DE69728536D1 (en) PREPARATIONS CONTAINS A NITRONE COMPOUND FOR USE IN THE TREATMENT OF UVEITIS
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
EP0373771A3 (en) New pharmaceutical uses for cystatins
CA2283450A1 (en) Methods for treatment of scar tissue
ES2063440T3 (en) USE OF POLYSACCHARIDES IN PREPARATIONS FOR WOUND TREATMENT.